Edwards Lifesciences to spend $1.2B on two more M&A deals
Edwards Lifesciences is continuing its M&A run with two more major deals. The cardiac device company announced yesterday evening that it will spend $1.2 billion to acquire two companies: JenaValve Technology and Endotronix. The news came at the same time that the cardiac device company reported a second-quarter revenue miss and reduced TAVR guidance. As of midday today, EW shares had plummeted more than 26% to $63.85 apiece; MassDevice‘s MedTech 100 Index was down slightly.
